Publications by authors named "Brett Lowe"

Claim this Profile
M
Memory B-cells elicited by different HPV vaccine regimens in the DoRIS randomised controlled trial.
Rebecca Wiggins, Kathy J Baisley, Jackton Indangasi, John Changalucha, Helen Ashwin, Brett Lowe

NPJ Vaccines· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial.
Deborah Watson-Jones, John Changalucha, Caroline Maxwell, Hilary Whitworth, Paul Mutani, Brett Lowe

Lancet Glob Health· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Andrew W Lee, Ken Liu, Edouard Lhomme, Julie Blie, John McCullough, Brett Lowe

Clin Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an Ad26.ZEBOV booster vaccine in Human Immunodeficiency Virus positive (HIV+) adults previously vaccinated with the Ad26.ZEBOV, MVA-BN-Filo vaccine regimen against Ebola: A single-arm, open-label Phase II clinical trial in Kenya and Uganda.
Edward Man-Lik Choi, Ggayi Abu-Baker Mustapher, Gloria Omosa-Manyonyi, Julie Foster, Zacchaeus Anywaine, Brett Lowe

Vaccine· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Edward Man-Lik Choi, Boris Lacarra, Muhammed O Afolabi, Boni Maxime Ale, Frank Baiden, Brett Lowe

Lancet Glob Health· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.
Daniela Manno, Catriona Patterson, Abdoulie Drammeh, Kevin Tetteh, Mattu Tehtor Kroma, Brett Lowe

Vaccines (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study.
Bolarinde J Lawal, Katherine E Gallagher, Jonathan Kitonsa, Daniel Tindanbil, Kambale Kasonia, Brett Lowe

Int J Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.
Daniela Manno, Agnes Bangura, Frank Baiden, Abu Bakarr Kamara, Philip Ayieko, Brett Lowe

Lancet Infect Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Dennis O Odera, James Tuju, Kennedy Mwai, Irene N Nkumama, Kristin Fürle, Brett Lowe

Sci Transl Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.
Deborah Watson-Jones, John Changalucha, Hilary Whitworth, Ligia Pinto, Paul Mutani, Brett Lowe

Lancet Glob Health· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols.
Frank Baiden, Suzanne Fleck, Bailah Leigh, Philip Ayieko, Daniel Tindanbil, Brett Lowe

PLoS One· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
Daniela Manno, Philip Ayieko, David Ishola, Muhammed O Afolabi, Baimba Rogers, Brett Lowe

Emerg Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
Muhammed O Afolabi, David Ishola, Daniela Manno, Babajide Keshinro, Viki Bockstal, Brett Lowe

Lancet Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
David Ishola, Daniela Manno, Muhammed O Afolabi, Babajide Keshinro, Viki Bockstal, Brett Lowe

Lancet Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observational study: 27 years of severe malaria surveillance in Kilifi, Kenya.
Patricia Njuguna, Kathryn Maitland, Amek Nyaguara, Daniel Mwanga, Polycarp Mogeni, Brett Lowe

BMC Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing a quality management system using good clinical laboratory practice guidelines at KEMRI-CMR to support medical research.
Horace Gumba, Joseph Waichungo, Brett Lowe, Alfred Mwanzu, Robert Musyimi

Wellcome Open Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of Good Clinical Laboratory Practice in an Immunology Basic Research Laboratory: The KEMRI-Wellcome Trust Research Laboratories Experience.
Horace Gumba, Jennifer Musyoki, Moses Mosobo, Brett Lowe

Am J Clin Pathol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for community-acquired pneumonia among adults in Kenya: a case-control study.
Esther Muthumbi, Brett S Lowe, Cyprian Muyodi, Esther Getambu, Fergus Gleeson

Pneumonia (Nathan)· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study.
Jesse Gitaka, Caroline Ogwang, Moses Ngari, Pauline Akoo, Ally Olotu, Brett Lowe

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries.
Anna C Seale, Coll Hutchison, Silke Fernandes, Nicole Stoesser, Helen Kelly, Brett Lowe

Wellcome Open Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.

Am J Hum Genet· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study.
Polycarp Mogeni, Thomas N Williams, Gregory Fegan, Christopher Nyundo, Evasius Bauni, Brett Lowe

PLoS Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacteraemia in sickle cell anaemia is associated with low haemoglobin: a report of 890 admissions to a tertiary hospital in Tanzania.
Julie Makani, Josephine Mgaya, Emmanuel Balandya, Khadija Msami, Deogratias Soka, Brett Lowe

Br J Haematol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya.
Susanne H Hodgson, Elizabeth Juma, Amina Salim, Charles Magiri, Daniel Njenga, Brett Lowe

Malar J· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection.
Susanne H Hodgson, Elizabeth Juma, Amina Salim, Charles Magiri, Domtila Kimani, Brett Lowe

Front Microbiol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis